Ambisome
Payments companies reported to CMS as associated with Ambisome. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ambisome, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ambisome
These are the largest totals companies reported as associated with Ambisome. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Luis Ostrosky | Houston, TX | Infectious Disease | $32,317.00 |
| Lilian Abbo | Miami, FL | Infectious Disease | $11,831.61 |
| Andrej Spec | Saint Louis, MO | Infectious Disease | $6,660.00 |
| Cornelius Clancy | Gainesville, FL | Infectious Disease | $3,230.00 |
| Felicia Mackey | Sacramento, CA | Family | $348.60 |
| Walter Martin | Roseville, CA | Pulmonary Disease | $328.75 |
| Meryl Perez | Roseville, CA | Infectious Disease | $276.74 |
| Imran Mohammed | Roseville, CA | Critical Care Medicine (Internal Medicine) | $217.83 |
| Francesco Aiello | Worcester, MA | Vascular Surgery | $209.09 |
| Lourdes Vazquez | San Juan, PR | General Practice | $190.92 |
Prescribed Ambisome?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.